Glucose-6-phosphate dehydrogenase activity is more advanced in cancerous cells than in normal cells, and blocking G6PD in cancer cells causes diminished proliferation and greater apoptosis in vitro (Preuss et al., 2013). Here, G6PD is linked to cancer.